As of May 2024 Zogenix has a market cap of $1.50 Billion. This makes Zogenix the world's 4653th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.50 B | 64.88% |
2021 | $0.90 B | -18.24% |
2020 | $1.11 B | -52.84% |
2019 | $2.36 B | 53.83% |
2018 | $1.53 B | 11.83% |
2017 | $1.37 B | 355.43% |
2016 | $0.30 B | -17.51% |
2015 | $0.36 B | 73.79% |
2014 | $0.21 B | -56.04% |
2013 | $0.47 B | 256.45% |
2012 | $0.13 B | -7.35% |
2011 | $0.14 B | -24.97% |
2010 | $0.19 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $366.86 B | 24,354.70% | ๐บ๐ธ USA |
Pfizer PFE | $162.60 B | 10,738.95% | ๐บ๐ธ USA |
Eli Lilly LLY | $744.40 B | 49,521.32% | ๐บ๐ธ USA |
Merck MRK | $333.21 B | 22,111.90% | ๐บ๐ธ USA |
Cardinal Health CAH | $24.02 B | 1,501.51% | ๐บ๐ธ USA |
Antares Pharma ATRS | $0.95 B | -36.34% | ๐บ๐ธ USA |
Alkermes ALKS | $4.13 B | 175.46% | ๐ฎ๐ช Ireland |
Nektar Therapeutics
NKTR | $0.31 B | -78.89% | ๐บ๐ธ USA |